This page lists ClinicalTrials.gov records that name Gonadorelin among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.
Search
Compound
All compounds
Gonadorelin
Phase
All phases
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Observational
Not applicable
Expanded access
Status
All statuses
No registered studies match that search or filter.
Recruiting Phase 1 Gonadorelin
NCT ID NCT07783282
Sponsor Astellas Pharma Global Development, Inc.
Registry dates 2026-09-25 – 2027-04-30
Enrollment 56 registered participants
Locations Bulgaria
Conditions listed Prostate Cancer Registry record on ClinicalTrials.gov
Not yet recruiting Phase 1, Phase 2 Gonadorelin
NCT ID NCT07653282
Sponsor Assiut University
Registry dates 2026-08-01 – 2028-08-01
Enrollment 122 registered participants
Locations Egypt
Conditions listed GnRH Agonist Registry record on ClinicalTrials.gov
Not yet recruiting Observational Gonadorelin
NCT ID NCT07642700
Sponsor Guoxia Yang
Registry dates 2026-06-01 – 2028-06-01
Enrollment 150 registered participants
Conditions listed Chronic Endometritis Registry record on ClinicalTrials.gov
Recruiting Phase 4 Gonadorelin Triptorelin
NCT ID NCT07696351
Sponsor Li-jun Ding
Registry dates 2025-08-01 – 2027-07-31
Enrollment 120 registered participants
Locations China
Conditions listed Deep Infiltrating Endometriosis (DIE); Infertility Registry record on ClinicalTrials.gov
Active, not recruiting Phase 1 Gonadorelin
NCT ID NCT06531499
Sponsor Novartis Pharmaceuticals
Registry dates 2024-11-11 – 2029-04-24
Enrollment 110 registered participants
Locations United States, Germany, Netherlands +3 more
Conditions listed Metastatic Castration-Resistant Prostate Cancer Registry record on ClinicalTrials.gov
Active, not recruiting Phase 1 Gonadorelin
NCT ID NCT06379217
Sponsor Novartis Pharmaceuticals
Registry dates 2024-07-29 – 2026-10-09
Enrollment 31 registered participants
Locations United States, France, Germany +2 more
Conditions listed Metastatic Neuroendocrine Prostate Cancer Registry record on ClinicalTrials.gov
Recruiting Not applicable Gonadorelin
NCT ID NCT06239376
Sponsor Mỹ Đức Hospital
Registry dates 2024-02-19 – 2027-05-30
Enrollment 222 registered participants
Locations Vietnam
Conditions listed Adenomyosis; IVF; Frozen Embryo Transfer Registry record on ClinicalTrials.gov
Unknown status Not applicable Gonadorelin HCG
NCT ID NCT06142708
Sponsor Embryolab Fertility Clinic
Registry dates 2023-11-01 – 2026-02
Enrollment 80 registered participants
Locations Greece
Conditions listed Ovarian Stimulation; Human Chorionic Gonadotropin; Oocyte Donors Registry record on ClinicalTrials.gov
Terminated Phase 4 Gonadorelin Results posted
NCT ID NCT05700903
Sponsor University of Colorado, Denver
Registry dates 2023-09-20 – 2025-07-16
Enrollment 10 registered participants
Locations United States
Conditions listed Androgen Deprivation Therapy; Prostate Cancer; Hypertension; Autonomic Dysfunction +1 more Registry record on ClinicalTrials.gov
Unknown status Phase 4 Gonadorelin
NCT ID NCT05937490
Sponsor Azienda Ospedaliero-Universitaria di Modena
Registry dates 2023-03-27 – 2025-03
Enrollment 500 registered participants
Locations Italy
Conditions listed Adenomyosis Registry record on ClinicalTrials.gov
Unknown status Not applicable Gonadorelin HCG
NCT ID NCT05838105
Sponsor Shaare Zedek Medical Center
Registry dates 2022-10-01 – 2025-01-01
Enrollment 144 registered participants
Locations Israel
Conditions listed Luteal Phase Support Registry record on ClinicalTrials.gov
Recruiting Phase 2, Phase 3 Gonadorelin
NCT ID NCT05316935
Sponsor Xiaojun Chen
Registry dates 2022-07-13 – 2028-03-30
Enrollment 80 registered participants
Locations China
Conditions listed Endometrial Neoplasms; Atypical Endometrial Hyperplasia; Progesterone Resistance Registry record on ClinicalTrials.gov
Completed Observational Gonadorelin
NCT ID NCT05122377
Sponsor Fudan University
Registry dates 2022-03-01 – 2025-05-01
Enrollment 562 registered participants
Locations China
Conditions listed Breast Cancer; Quality of Life; Hormone Receptor-positive Breast Cancer Registry record on ClinicalTrials.gov
Unknown status Phase 4 Gonadorelin
NCT ID NCT04487925
Sponsor University Hospital, Ghent
Registry dates 2022-01-25 – 2024-12-31
Enrollment 208 registered participants
Locations Belgium
Conditions listed Ovarian Reserve; Poor Responders; IVF Registry record on ClinicalTrials.gov
Unknown status Not applicable Gonadorelin
NCT ID NCT05184374
Sponsor Huashan Hospital
Registry dates 2022-01-01 – 2022-12-31
Enrollment 20 registered participants
Locations China
Conditions listed Hypogonadotropic Hypogonadism Registry record on ClinicalTrials.gov
Active, not recruiting Phase 4 Gonadorelin
NCT ID NCT05057546
Sponsor University of Colorado, Denver
Registry dates 2021-11-22 – 2025-07-28
Enrollment 55 registered participants
Locations United States
Conditions listed Menopause; Estrogen Deficiency; Women; Aging Registry record on ClinicalTrials.gov
Completed Phase 3 Gonadorelin
NCT ID NCT05189873
Sponsor Tehran University of Medical Sciences
Registry dates 2021-06-10 – 2022-01-03
Enrollment 128 registered participants
Locations Iran
Conditions listed Polycystic Ovary Syndrome; Infertility, Female Registry record on ClinicalTrials.gov
Recruiting Phase 2, Phase 3 Gonadorelin
NCT ID NCT04356664
Sponsor Hopital Foch
Registry dates 2021-03-18 – 2026-06-18
Enrollment 180 registered participants
Locations France
Conditions listed Endometriosis; Adenomyosis; Infertility, Female Registry record on ClinicalTrials.gov
Recruiting Phase 2, Phase 3 Gonadorelin
NCT ID NCT04390646
Sponsor Nelly Pitteloud
Registry dates 2020-08-27 – 2028-12
Enrollment 56 registered participants
Locations Switzerland
Conditions listed Down Syndrome; Cognitive Decline; Alzheimer Disease, Early Onset; Olfaction Disorders Registry record on ClinicalTrials.gov
Active, not recruiting Early Phase 1 Gonadorelin
NCT ID NCT04037605
Sponsor Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Registry dates 2020-02-09 – 2026-06-24
Enrollment 5 registered participants
Locations United States
Conditions listed Sleep Restriction Registry record on ClinicalTrials.gov
Completed Not applicable Gonadorelin
NCT ID NCT04108039
Sponsor Fundacion Dexeus
Registry dates 2019-09-25 – 2022-05-15
Enrollment 44 registered participants
Locations Spain
Conditions listed Infertility; IVF; Preimplantation Diagnosis Registry record on ClinicalTrials.gov
Unknown status Phase 4 Gonadorelin
NCT ID NCT03989024
Sponsor RenJi Hospital
Registry dates 2019-07-01 – 2021-12-30
Enrollment 78 registered participants
Locations China
Conditions listed Polycystic Ovary Syndrome; Infertility; Ovulation Disorder Registry record on ClinicalTrials.gov
Completed Phase 2 Gonadorelin Kisspeptin-10 Results posted
NCT ID NCT04648969
Sponsor Stephanie B. Seminara, MD
Registry dates 2019-05-03 – 2025-08-31
Enrollment 18 registered participants
Locations United States
Conditions listed Hypogonadotropic Hypogonadism Registry record on ClinicalTrials.gov
Active, not recruiting Phase 2 Gonadorelin Results posted
NCT ID NCT03809000
Sponsor RTOG Foundation, Inc.
Registry dates 2019-04-15 – 2029-09-15
Enrollment 188 registered participants
Locations United States, Canada
Conditions listed Prostate Cancer Registry record on ClinicalTrials.gov
Completed Observational Gonadorelin
NCT ID NCT03867357
Sponsor Seattle Institute for Biomedical and Clinical Research
Registry dates 2018-12-07 – 2023-09-01
Enrollment 60 registered participants
Locations United States
Conditions listed Metastatic Prostate Cancer; Androgen Deprivation Therapy Registry record on ClinicalTrials.gov